Recalls & Warnings February 17, 2022 Seller of L-Theanine, Lutein, Noopept and More Warned for Drug Claims On February 4, 2022, the FDA issued a warning letter to Crystal Clear Supplements following a review of the companys website and social media which found statements about Tianeptine Sodium Powder, Tianeptine Sulfate Powder, PEA Capsules, Phenibut Capsules, Synephrine Powder, Noopept
We're still waiting for them
A recent human study presented at the Endocrine Society meeting found that obese men treated with GLP1 receptor agonists, including semaglutide, dulaglutide or tirzepatide, experienced a rise in normal testosterone levels from 53 percent to 77 percent over 18 months (closely correlated with weight loss), demonstrating how peptide-based therapies can effectively support and restore healthy testosterone production
Rosenzweig ES, Courtine G, Jindrich DL, Brock JH, Ferguson AR, Strand SC, et al
However, quality control obligations for compounding pharmacies are less strict than those governing FDA-approved drug manufacturers